DYN

Dyne Therapeutics, Inc.

33.44 USD
-0.25 (-0.74%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Dyne Therapeutics, Inc. stock is up 13.82% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 11 June’s closed higher than May. In the last 4 Unusual Options Trades, there were 4 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
24 Apr 16:10 21 Jun, 2024 22.50 CALL 99 179
02 May 18:13 21 Jun, 2024 30.00 CALL 1495 235
20 May 15:26 21 Jun, 2024 30.00 CALL 75 1967
20 May 15:28 21 Jun, 2024 30.00 CALL 70 1967

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a muscle disease company, focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

  • Chardan Capital
    Tue May 21, 08:14
    buy
    confirm
  • Jefferies
    Mon May 20, 13:30
    buy
    confirm
  • HC Wainwright & Co.
    Mon May 20, 09:30
    buy
    confirm